CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.

CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Satsangi, J, Simmons, J, Marshall, S, Mitchell, S, Chapman, R, Welsh, K, Jewell, D
Μορφή:	Journal article
Έκδοση:	2000

Παρόμοια τεκμήρια

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis
ανά: Chapman, R, κ.ά.
Έκδοση: (1986)

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
ανά: Chapman, R, κ.ά.
Έκδοση: (1986)

SERUM ANTI-COLON ANTIBODIES, ULCERATIVE-COLITIS, AND SCLEROSING CHOLANGITIS
ανά: Chapman, R, κ.ά.
Έκδοση: (1983)

THE HISTOLOGICAL FEATURES OF SCLEROSING CHOLANGITIS ASSOCIATED WITH CHRONIC ULCERATIVE-COLITIS
ανά: Barbatis, C, κ.ά.
Έκδοση: (1983)

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.
ανά: Snook, J, κ.ά.
Έκδοση: (1989)

Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis.
ανά: Barbatis, C, κ.ά.
Έκδοση: (1985)

Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?
ανά: Jayaram, H, κ.ά.
Έκδοση: (2001)

Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?
ανά: Jayaram, H, κ.ά.
Έκδοση: (2001)

Ulcerative colitis: sclerosing cholangitis today, cancer tomorrow?
ανά: Broomé, U, κ.ά.
Έκδοση: (1997)

Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
ανά: Snook, J, κ.ά.
Έκδοση: (1989)

A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.
ανά: Satsangi, J, κ.ά.
Έκδοση: (2001)

Carcinoma of the gallbladder in ulcerative colitis and primary sclerosing cholangitis. Report of two cases.
ανά: Dorudi, S, κ.ά.
Έκδοση: (1991)

Clinical Characterization of Ulcerative Colitis in Patients with Primary Sclerosing Cholangitis
ανά: Shun Murasugi, κ.ά.
Έκδοση: (2020-01-01)

Characteristic features of ulcerative colitis with concomitant primary sclerosing cholangitis
ανά: Artur W. Uździcki, κ.ά.
Έκδοση: (2021-09-01)

Rapid Progression of Primary Sclerosing Cholangitis Complicated with Ulcerative Colitis
ανά: Piotr Pardak, κ.ά.
Έκδοση: (2015-01-01)

Hypereosinophilic Syndrome Secondary to Ulcerative Colitis and Primary Sclerosing Cholangitis
ανά: Davi Viana Ramos, κ.ά.
Έκδοση: (2023-01-01)

IGG SUBCLASS DISTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
ανά: Bansi, D, κ.ά.
Έκδοση: (1995)

A regulatory polymorphism of the stromelysin gene (MMP-3) strongly influences susceptibility to primary sclerosing cholangitis (PSC) and progression to portal hypertension.
ανά: Satsangi, J, κ.ά.
Έκδοση: (2000)

Primary sclerosing cholangitis.
ανά: Mitchell, SA, κ.ά.
Έκδοση: (2000)

Antigen specificity of antineutrophil antibodies in ulcerative colitis, primary sclerosing cholangitis and autoimmune hepatitis
ανά: Bansi, D, κ.ά.
Έκδοση: (1996)

ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
ανά: Snook, J, κ.ά.
Έκδοση: (1988)

Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis
ανά: Johan Vessby, κ.ά.
Έκδοση: (2019-10-01)

Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
ανά: Manon de Krijger, κ.ά.
Έκδοση: (2022-03-01)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES ARE ABSENT IN UNAFFECTED RELATIVES OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
ανά: Bansi, D, κ.ά.
Έκδοση: (1995)

The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
ανά: Mehal, W, κ.ά.
Έκδοση: (1994)

Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
ανά: Bansi, D, κ.ά.
Έκδοση: (1996)

The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
ανά: Chapman, R
Έκδοση: (1995)

The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis.
ανά: Rahman, M, κ.ά.
Έκδοση: (2011)

Primary sclerosing cholangitis--an immunologically mediated disease?
ανά: Chapman, R, κ.ά.
Έκδοση: (1985)

Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
ανά: Lo, S, κ.ά.
Έκδοση: (1992)

The management of primary sclerosing cholangitis.
ανά: Mitchell, SA, κ.ά.
Έκδοση: (1998)

Ulcerative Colitis, Autoimmune Hemolytic Anemia and Primary Sclerosing Cholangitis in a Child
ανά: Susan M Gilmour, κ.ά.
Έκδοση: (1996-01-01)

Impact of clinical manifestations and outcome of ulcerative colitis with primary sclerosing cholangitis in children
ανά: Chuen-Bin Jiang
Έκδοση: (2021-09-01)

Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis
ανά: Ramon V. Cortez, κ.ά.
Έκδοση: (2021-02-01)

Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man
ανά: José Cândido Caldeira Xavier Júnior, κ.ά.
Έκδοση: (2013-12-01)

Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis
ανά: Agnieszka Kempinska-Podhorodecka, κ.ά.
Έκδοση: (2021-05-01)

Sclerosing cholangitis
ανά: Martins, E, κ.ά.
Έκδοση: (1998)

Sclerosing cholangitis
ανά: Martins, E, κ.ά.
Έκδοση: (1997)

Sclerosing cholangitis.
ανά: Björnsson, E, κ.ά.
Έκδοση: (2003)

Sclerosing cholangitis.
ανά: Martins, E, κ.ά.
Έκδοση: (2001)